As cycle time becomes the new currency of drug development, life sciences R&D leaders are looking to expedite adoption of AI and risk management for greater efficiency across the clinical trial ...

AI medical scribe company Abridge's closest partner and former shareholder, health records giant Epic, has become its biggest ...

In recent years, significant therapeutic advances across multiple disease areas—including immuno-oncology, metabolic diseases such as type 2 diabetes and ...

Alyssa Bilinski, a researcher at Brown University, joined 12 News at 4 Wednesday to discuss Trump’s claim and risks of medication in pregnant women.